<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study</article-title>
</title-group>
